Clinical Trial Update: Real-World Analysis of Belantamab Mafodotin Care Patterns in Patients With Relapsed and/or Refractory Multiple Myeloma

View source ↗

Summary

This completed real-world analysis examines patterns of belantamab mafodotin use in patients with relapsed/refractory multiple myeloma and describes care patter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Blenrep (belantamab mafodotin)

Snippet

Sponsor: Duke University | Conditions: Multiple Myeloma | Status: COMPLETED | Results posted: 2025-02-03